Skip To Main Content
Yinan Ding on Muck Rack

Yinan Ding

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinan

Contact Yinan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients

|
By Chuanyong Zhang, Jiangsu province, Luhong Wang, Yinan Ding
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the coronavirus disease (COVID-19), which poses a major threat to humans worldwide. With the continuous progress of the pandemic, a growing number of people are infected with SARS-CoV-2, including hepatocellular carcinoma (HCC) patients. However, the relationship between COVID-19 and HCC has not been fully elucidated.
Open in Who Shared Issue with article?
See all 1 articles